Artificial Intelligence In Drug Discovery Market is
Jersey City, New Jersey, Dec. 14, 2022 (GLOBE NEWSWIRE) — Verified Market Research® recently published a report, “Artificial Intelligence in Drug Discovery Market” By Technology (Machine Learning, Deep Learning), By Application (Cardiovascular Diseases, Immuno-oncology), By End User (Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and By Geography.
According to the in-depth research conducted by Verified Market Research®, the global Artificial Intelligence In Drug Discovery Market size was valued at USD 175.91 Million in 2018 and is projected to reach USD 2,589.81 Million by 2026, growing at a CAGR of 39.9 % from 2019 to 2026.
Download PDF brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=29986
Browse in-depth TOC on “Artificial Intelligence in Drug Discovery Market“
202 – Pages
126 – Tables
37 – Figures
Global Artificial Intelligence in Drug Discovery Market
Artificial intelligence is a product of computer-aided drug development (AI). This expansion is fueled by the widespread application of machine learning, particularly deep learning, in various scientific fields as well as advances in computer hardware and software. Unlike natural intelligence developed by animals such as humans, artificial intelligence is a type of machine intelligence (AI). The study of “intelligent agents,” or systems that are aware of their environment and take actions to improve their chances of success, is known as artificial intelligence (AI). The various subfields of artificial intelligence technologies are based on specific goals and the use of certain methods.
Conventional AI research targets include the development of thinking, information processing, planning, learning, voice recognition, sensation and the ability to move and control objects. One of the long-term goals of the area in general intelligence (the ability to solve any problem).
Artificial intelligence in the pharmaceutical industry has the ability to find hit and lead compounds, improve the design of drug structures and provide faster confirmation of the medicinal target, all of which are expected to increase demand. The determination of relevant interactions in medical tests is also facilitated by AI, which helps reduce the chance of false positive results through careful parameter design. Another aspect influencing the industry’s growth is its ability to move pharmaceutical screening from the bench to a virtual laboratory, where results from a screen can be produced more quickly and intriguing targets can be found without the need for significant experimental inputs and labor hours.
The enormous data sets accessible to drug research in pharmaceutical businesses, containing millions of elements, may be too much for artificial intelligence algorithms to handle. This is expected to slow down the development of artificial intelligence in the drug discovery market in the near future.
Verified Market Research® narrows down the available data by using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative assessment of market elements that interest the client. The “Global Artificial Intelligence In Drug Discovery Market” is primarily divided into sub-segments that can provide classified data on the latest trends in the market.
Key players
The “Global Artificial Intelligence In Drug Discovery Market” study report will provide valuable insight with an emphasis on the global market. The most important players in the market are NVIDIA Corporation, Deep Genomics, IBM Corporation, Cloud Pharmaceuticals, Microsoft, Google, Atomwise, Inc., Insilico Medicine, BenevolentAI and Exscientia.
Based on the research, Verified Market Research® has segmented the global artificial intelligence in drug discovery market into technology, application, end-user, and geography.
- Artificial intelligence in drug discovery market, through technology
- Machine learning
- Deep learning
- Supervised learning
- Reinforcement learning
- Other
- Artificial Intelligence in Drug Discovery Market, by Application
- Cardiovascular diseases
- Immuno-oncology
- Metabolic diseases
- Neurodegenerative diseases
- Other
- Artificial Intelligence in Drug Discovery Market, by End User
- Contract research organizations
- Pharmaceutical and Biotechnology Companies
- Research Centers and Academic and Government Institutions
- Artificial Intelligence in Drug Discovery Market, by Geography
- North America
- Europe
- Germany
- France
- UK
- Rest of Europe
- Asian Pacific Ocean
- China
- Japan
- In the
- Rest of Asia Pacific
- ROW
- Middle East and Africa
- Latin America
Browse related reports:
No-expression market By Consumables (Reagents, DNA Chips), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS)), By Service (Gene Expression Profiling Services, Bioinformatics Solutions), By Application (Research, Drug Discovery, Diagnostics), By Geography and prediction
Cancer Biomarkers Market By cancer type (breast cancer, prostate cancer), by biomarker type (protein biomarkers, genetic biomarkers), by profiling technology (OMICS technology, imaging technology), by application (drug discovery and development, diagnostics), by geography and forecasting
Anatomic Pathology Market By Product & Service (Instruments, Consumables), By Application (Disease Diagnosis, Drug Discovery & Development), By End User (Hospitals, Diagnostic Labs, Research Labs), By Geography & Forecast
Label-free drug discovery market By Product (Cellular Dielectric Spectroscopy, Bio-Layer Interferometry, Surface Plasmon Resonance, Optical Waveguide Grating Technology), By Application (Pharmaceutical Companies, Research Laboratories, Others), By Geography and Forecast
Top 10 next generation sequencing companies changing lives with genome research
Visualize artificial intelligence in drug discovery market using verified market intelligence -:
Verified market intelligence are we BI enabled platform for narrative storytelling in this market. VMI provides in-depth forecasted trends and accurate insights on over 20,000+ emerging and niche markets, helping you make critical decisions that impact revenue for a brilliant future.
VMI provides a holistic overview and global competitive landscape regarding region, country, segment and key players of your market. Present your market report and findings with a built-in presentation function that saves more than 70% of your time and resources for investors, sales and marketing, R&D and product development. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.
About us
Verified Market Research® is a leading global research and consulting firm serving over 5000+ clients. Verified Market Research® offers advanced analytical research solutions while presenting information-enriched research studies. We provide insight into strategic and growth analyses, Data needed to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and management use industrial techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to deliver insightful and accurate research.
We study 14+ categories of Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agricultural Industry and Medical Devices from over 100 countries.
